Pregled bibliografske jedinice broj: 144466
Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related posttraumatic stress disorder
Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related posttraumatic stress disorder // Psychopharmacology, 175 (2004), 4; 451-456 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 144466 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related posttraumatic stress disorder
Autori
Pivac, Nela ; Kozarić-Kovačić, Dragica ; Muck-Šeler, Dorotea
Izvornik
Psychopharmacology (0033-3158) 175
(2004), 4;
451-456
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Combat-Related Posttraumatic Stress Disorder; Psychotic symptoms; Olanzapine; Fluphenazine
Sažetak
Rationale Combat-related posttraumatic stress disorder (PTSD) is often complicated with other psychiatric comorbidities, and refractory to treatment. Objective The aim of an open, comparative 6-week study was to compare olanzapine and fluphenazine, as a monotherapy, for treating psychotic combat-related PTSD. Method Fifty-five male war veterans with psychotic PTSD (DSM-IV criteria) were treated for 6 weeks with olanzapine (N=28) or fluphenazine (N=27) in a 5-10 mg/day dose range, once or twice daily. Patients were evaluated at baseline, and after 3 and 6 weeks of treatment, using Watson's PTSD scale, Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Severity Scale (CGI-S), Clinical Global Impression Improvement Scale (CGI-I), Patient Global Impression Improvement Scale (PGI-I) and Drug Induced Extra-Pyramidal Symptoms Scale (DIEPSS). Results At baseline, patient's data (age, duration of combat experience and scores in all measurement instruments) did not differ. After 3 and 6 weeks of treatment, olanzapine was significantly more efficacious than fluphenazine in reducing symptoms in PANSS (negative, general psychopathology subscale, supplementary items), Watson's PTSD (avoidance, increased arousal) subscales, CGI-S, CGI-I, and PGI-I scale. Both treatments affected similarly the symptoms listed in PANSS positive and Watson's trauma reexperiencing subscales. Fluphenazine induced more extrapyramidal symptoms. Prolongation of the treatment for 3 additional weeks did not affect the efficacy of either drug. Conclusions Our data indicate that both fluphenazine and olanzapine were effective for particular symptom profile in psychotic combat-related PTSD. Olanzapine was better than fluphenazine in reducing most of the psychotic and PTSD symptoms, and was better tolerated in psychotic PTSD patients.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0098088
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica
- Index Medicus